Matches in Wikidata for { <http://www.wikidata.org/entity/Q90455945> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- Q90455945 description "2019 թվականին հրատարակված գիտական հոդված" @default.
- Q90455945 description "article scientifique (publié 2019)" @default.
- Q90455945 description "articolo scientifico (pubblicato il 2019)" @default.
- Q90455945 description "artigo científico (publicado na 2019)" @default.
- Q90455945 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q90455945 description "artículo científico publicado en 2019" @default.
- Q90455945 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q90455945 description "im Jahr 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90455945 description "scientific article published on 01 January 2019" @default.
- Q90455945 description "wetenschappelijk artikel" @default.
- Q90455945 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q90455945 description "научна статия" @default.
- Q90455945 name "The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities" @default.
- Q90455945 name "The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities" @default.
- Q90455945 name "The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities" @default.
- Q90455945 type Item @default.
- Q90455945 label "The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities" @default.
- Q90455945 label "The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities" @default.
- Q90455945 label "The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities" @default.
- Q90455945 prefLabel "The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities" @default.
- Q90455945 prefLabel "The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities" @default.
- Q90455945 prefLabel "The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities" @default.
- Q90455945 P1433 Q90455945-99A31020-9009-4781-85EF-FCF93F029E66 @default.
- Q90455945 P1476 Q90455945-A3BB287F-238F-47F3-AA72-01489398CDEE @default.
- Q90455945 P2093 Q90455945-0074725F-91F0-4D74-9442-920D70A36F98 @default.
- Q90455945 P2093 Q90455945-00E3D2CD-B406-41C2-9250-A42EB1AB9D7B @default.
- Q90455945 P2093 Q90455945-155FF88B-8C2F-4682-BF47-1D10BAEA8759 @default.
- Q90455945 P2093 Q90455945-285420E9-80D1-4FB3-A7F0-75CDADD6218A @default.
- Q90455945 P2093 Q90455945-2E8CE01B-D53C-4B26-97C9-88A352AA93FC @default.
- Q90455945 P2093 Q90455945-31227823-4708-4757-90F8-BE2A8338AF41 @default.
- Q90455945 P2093 Q90455945-3A266241-BF04-4C50-B12E-3A997DC4BB4E @default.
- Q90455945 P2093 Q90455945-534393F5-2743-44BD-BF06-4AF8985993F1 @default.
- Q90455945 P2093 Q90455945-5E40F76C-16A1-44C2-84E2-BC308022C0EA @default.
- Q90455945 P2093 Q90455945-6445FA6A-8F05-4F84-A130-35BC616B7F2E @default.
- Q90455945 P2093 Q90455945-785A7796-1255-43FD-9026-7BFF57D82129 @default.
- Q90455945 P2093 Q90455945-79DCC617-62AF-49DA-8B02-36F9C8E8560C @default.
- Q90455945 P2093 Q90455945-7CD5D00E-662C-4549-8223-2CEFBB430388 @default.
- Q90455945 P2093 Q90455945-8473BE31-69AF-40BF-908F-300071B7B6AF @default.
- Q90455945 P2093 Q90455945-919E5DF9-A992-4C52-88E4-4CE0A9D8CCB4 @default.
- Q90455945 P2093 Q90455945-97B7023A-3AE3-4292-BCBC-1E51C75C5C45 @default.
- Q90455945 P2093 Q90455945-A9901573-8CB5-4E0D-9103-0F4EAF65C5E9 @default.
- Q90455945 P2093 Q90455945-BB6599C9-7586-42EC-95FF-22D8D8705790 @default.
- Q90455945 P2093 Q90455945-CB18984C-504D-4577-A860-D6F9463DA828 @default.
- Q90455945 P2093 Q90455945-E5F56B69-7D60-4CB0-83F3-163299C17CC9 @default.
- Q90455945 P2093 Q90455945-EDDCADD9-E3E8-48B0-B86A-5A509E62CEE9 @default.
- Q90455945 P2093 Q90455945-EDFC631D-4EE9-40EA-B7A9-2B5C2EFA49D9 @default.
- Q90455945 P2093 Q90455945-EFB0143B-D7C0-4E82-977C-25F857750EEF @default.
- Q90455945 P275 Q90455945-3a4464bc-25d6-4972-a8ee-2015b8160978 @default.
- Q90455945 P304 Q90455945-B8457F8B-68F9-40F9-AFA7-7CB3F1E8AE88 @default.
- Q90455945 P31 Q90455945-4421E2F7-CFDD-49A9-B7EA-3BB396BBB119 @default.
- Q90455945 P356 Q90455945-C2BF5981-88FE-4B3A-A4EA-B633DB4DC1E3 @default.
- Q90455945 P433 Q90455945-C5261B39-3EFE-45D1-B7A8-7929152F68BD @default.
- Q90455945 P478 Q90455945-22DB3EDC-0F1C-48D3-B950-928378F35CA8 @default.
- Q90455945 P577 Q90455945-95A2AA0C-8BA0-4B7D-941B-FFB511340F85 @default.
- Q90455945 P6216 Q90455945-2c56d7ff-48de-4510-85d7-31f9a8afe1e9 @default.
- Q90455945 P356 JPPS30724 @default.
- Q90455945 P1433 Q15760233 @default.
- Q90455945 P1476 "The Requirements for Additional Strength Biowaivers for Immediate Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Differences and Commonalities" @default.
- Q90455945 P2093 "Alfredo Garcia-Arieta" @default.
- Q90455945 P2093 "Andrew Tam" @default.
- Q90455945 P2093 "April C Braddy" @default.
- Q90455945 P2093 "Arno Nolting" @default.
- Q90455945 P2093 "Aya Myoenzono" @default.
- Q90455945 P2093 "Ben Jones" @default.
- Q90455945 P2093 "Chantal Walther" @default.
- Q90455945 P2093 "Christopher Crane" @default.
- Q90455945 P2093 "Clare Rodrigues" @default.
- Q90455945 P2093 "Craig Simon" @default.
- Q90455945 P2093 "Diego Gutierrez Triana" @default.
- Q90455945 P2093 "Eduardo Agostinho Freitas Fernandes" @default.
- Q90455945 P2093 "Gustavo Mendes Lima Santos" @default.
- Q90455945 P2093 "Henrike Potthast" @default.
- Q90455945 P2093 "Ivan Omar Calderon" @default.
- Q90455945 P2093 "Joy Van Oudsthoorn" @default.
- Q90455945 P2093 "Matthias S Roost" @default.
- Q90455945 P2093 "Ryosuke Kuribayashi" @default.
- Q90455945 P2093 "Sang Aeh Park" @default.
- Q90455945 P2093 "So Young Eum" @default.
- Q90455945 P2093 "Wen-Yi Hung" @default.
- Q90455945 P2093 "Yusuke Okada" @default.
- Q90455945 P2093 "Zulema Rodriguez" @default.
- Q90455945 P275 Q18199165 @default.
- Q90455945 P304 "486-500" @default.
- Q90455945 P31 Q13442814 @default.
- Q90455945 P356 "10.18433/JPPS30724" @default.
- Q90455945 P433 "1" @default.
- Q90455945 P478 "22" @default.
- Q90455945 P577 "2019-01-01T00:00:00Z" @default.
- Q90455945 P6216 Q50423863 @default.